PubMed

Venous gangrene and cancer: a cool look at a burning issue.

Osman KA, Ahmed MH, Abdulla SA, Bucknall TE, Rogers CA.

Int Semin Surg Oncol. 2007 Mar 27;4:7.PMID: 17386114 [PubMed]Related articlesFree article

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J; American College of Chest Physicians.

Chest. 2008 Jun;133(6 Suppl):844S-886S.PMID: 18574280 [PubMed - indexed for MEDLINE]Related articlesFree article

Venous gangrene in a patient with adenocarcinoma of the lung.

Yang MH, Fan FS, Chen PM, Liu JH, Chiou TJ, Wang WS, Yen CC.

Jpn J Clin Oncol. 2000 Jun;30(6):276-8.PMID: 10939433 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.PMID: 17906973 [PubMed - indexed for MEDLINE]Related articles

The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.

Noble SI, Hood K, Finlay IG.

Palliat Med. 2007 Sep;21(6):473-6.PMID: 17846086 [PubMed - indexed for MEDLINE]Related articles

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.PMID: 17519445 [PubMed - indexed for MEDLINE]Related articles

Cancer, thrombosis and heparin-induced thrombocytopenia.

Prandoni P, Falanga A, Piccioli A.

Thromb Res. 2007;120 Suppl 2:S137-40. Erratum in: Thromb Res. 2008;123(1):187-90. PMID: 18023709 [PubMed - indexed for MEDLINE]Related articles

A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.

Rhodes S, Bond S.

Eur J Oncol Nurs. 2008 Dec;12(5):425-9. Epub 2008 Oct 7. Review.PMID: 18842458 [PubMed - indexed for MEDLINE]Related articles

Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.

Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Schünemann HJ.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006650. Review.PMID: 18425959 [PubMed - indexed for MEDLINE]Related articles

Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.

Nishioka J, Goodin S.

J Oncol Pharm Pract. 2007 Jun;13(2):85-97. Review.PMID: 17873108 [PubMed - indexed for MEDLINE]Related articles

Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic enoxaparin regimen.

Cunningham MS, Gilmore R, O'Donnell D, O'Donnell JS.

Ir J Med Sci. 2009 Sep;178(3):339-41. Epub 2008 Aug 27.PMID: 18751756 [PubMed - in process]Related articles

[Treatment of venous thromboembolic disease in cancer patients]

Farge-Bancel D, Florea L, Bosquet L, Debourdeau P.

Pathol Biol (Paris). 2008 Jun;56(4):220-8. Epub 2008 Apr 3. Review. French. PMID: 18394821 [PubMed - indexed for MEDLINE]Related articles

Does antithrombotic therapy improve survival in cancer patients?

Cunningham MS, Preston RJ, O'Donnell JS.

Blood Rev. 2009 May;23(3):129-35. Epub 2008 Nov 28. Review.PMID: 19046797 [PubMed - indexed for MEDLINE]Related articles

Efficacy of low- molecular- weight- heparin versus vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: a systematic review of randomized controlled trials.

Louzada ML, Majeed H, Wells PS.

Thromb Res. 2009 Apr;123(6):837-44. Epub 2008 Nov 1.PMID: 18977517 [PubMed - indexed for MEDLINE]Related articles

Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.

Ortel TL.

Hematology Am Soc Hematol Educ Program. 2009:225-32.PMID: 20008202 [PubMed - in process]Related articlesFree article

Cancer and thrombosis: implications of published guidelines for clinical practice.

Khorana AA.

Ann Oncol. 2009 Oct;20(10):1619-30. Epub 2009 Jun 26. Review.PMID: 19561038 [PubMed - indexed for MEDLINE]Related articles

Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.

Balibrea JL, Altimiras J, Larruzea I, Gómez-Outes A, Martínez-González J, Rocha E; Bemiparin Cooperative Study Group in Surgery for Cancer.

Int J Surg. 2007 Apr;5(2):114-9. Epub 2006 Nov 7.PMID: 17448976 [PubMed - indexed for MEDLINE]Related articles

Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.

Carrier M, Le Gal G, Cho R, Tierney S, Rodger M, Lee AY.

J Thromb Haemost. 2009 May;7(5):760-5. Epub 2009 Feb 24.PMID: 19245418 [PubMed - indexed for MEDLINE]Related articles

Diagnosis and initial treatment of venous thromboembolism in patients with cancer.

Streiff MB.

J Clin Oncol. 2009 Oct 10;27(29):4889-94. Epub 2009 Sep 8. Review.PMID: 19738109 [PubMed - indexed for MEDLINE]Related articles

Recurrent venous thromboembolism complicated by heparin-induced thrombocytopenia as a first manifestation of an occult cancer: a case report.

Pinto A, Tuttolomondo A, Fernandez P, Siragusa S, Di Raimondo D, Malato A, Di Sciacca R, La Placa S, Miceli S, Licata G.

Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):247-50.PMID: 18336754 [PubMed - indexed for MEDLINE]Related articles